Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Inventory (2019 - 2025)

Cresco Labs' Inventory history spans 7 years, with the latest figure at $98.7 million for Q4 2025.

  • For Q4 2025, Inventory rose 18.39% year-over-year to $98.7 million; the TTM value through Dec 2025 reached $98.7 million, up 18.39%, while the annual FY2025 figure was $98.7 million, 18.39% up from the prior year.
  • Inventory reached $98.7 million in Q4 2025 per CRLBF's latest filing, up from $83.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $136.6 million in Q4 2021 to a low of $83.3 million in Q4 2024.
  • Average Inventory over 5 years is $112.2 million, with a median of $107.8 million recorded in 2023.
  • Peak YoY movement for Inventory: skyrocketed 103.39% in 2021, then fell 22.68% in 2024.
  • A 5-year view of Inventory shows it stood at $136.6 million in 2021, then dropped by 1.49% to $134.6 million in 2022, then dropped by 19.92% to $107.8 million in 2023, then dropped by 22.68% to $83.3 million in 2024, then increased by 18.39% to $98.7 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Inventory are $98.7 million (Q4 2025), $83.3 million (Q4 2024), and $107.8 million (Q4 2023).